Compare LSCC & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LSCC | CRL |
|---|---|---|
| Founded | 1983 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.2B | 16.2B |
| IPO Year | 1994 | 1999 |
| Metric | LSCC | CRL |
|---|---|---|
| Price | $118.43 | $340.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 17 |
| Target Price | $156.19 | ★ $346.07 |
| AVG Volume (30 Days) | ★ 2.8M | 1.2M |
| Earning Date | 11-02-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.37 | ★ 6.48 |
| Revenue | $385,961,000.00 | ★ $1,857,601,000.00 |
| Revenue This Year | $89.72 | N/A |
| Revenue Next Year | $60.69 | $2.95 |
| P/E Ratio | $329.74 | ★ $53.25 |
| Revenue Growth | N/A | ★ 10.48 |
| 52 Week Low | $60.50 | $146.20 |
| 52 Week High | $157.01 | $379.63 |
| Indicator | LSCC | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 56.82 | 53.64 |
| Support Level | $111.52 | $311.68 |
| Resistance Level | $122.96 | $379.63 |
| Average True Range (ATR) | 6.78 | 17.92 |
| MACD | 2.77 | -2.55 |
| Stochastic Oscillator | 88.22 | 43.06 |
Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.